Gln-Topiramate 200 mg (Topiramate TABLET) 200 MG

GLN-Topiramate 200 MG tablets are a prescription medication used to manage certain types of seizures and prevent migraine headaches. This oral tablet is manufactured by Glenmark Pharmaceuticals Canada Inc.

Strength

200 MG

Pack Size

100

Manufacturer / TM Owner

GLENMARK PHARMACEUTICALS CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Topiramate is commonly prescribed for seizure control in conditions like epilepsy. It is also used to prevent migraine headaches. The medication works by affecting the nerves and chemicals in the body that may cause seizures or migraines. Topiramate 200 MG tablets are designed for oral administration and are available in a pack size of 100.

Side Effects

Common effects of topiramate may include dizziness, fatigue, and changes in taste. Some users may experience weight loss or cognitive changes. It is important to monitor for any unusual side effects and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Topiramate should be handled with care, especially for individuals with a history of kidney stones or metabolic acidosis. It is important to follow the prescribed dosage and avoid sudden discontinuation. Pregnant or breastfeeding women should consult a healthcare provider before use.

Avoid Interactions

Topiramate may interact with alcohol, leading to increased drowsiness. It can also interact with other medications that affect the central nervous system. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Topiramate is primarily used to control seizures in conditions like epilepsy and to prevent migraine headaches.

Topiramate tablets are taken orally, usually with or without food. Follow the dosage instructions provided by your healthcare provider.

Common side effects include dizziness, fatigue, changes in taste, and weight loss. Always consult a healthcare provider if side effects are severe or persistent.

It is generally advised to avoid alcohol while taking topiramate, as it can increase drowsiness and other side effects.

Pregnant women should consult their healthcare provider before taking topiramate, as it may have potential risks during pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.